A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice

SARS-CoV in 2003, SARS-CoV-2 in 2019, and SARS-CoV-2 variants of concern (VOC) can cause deadly infections, underlining the importance of developing broadly effective countermeasures against Group 2B Sarbecoviruses, which could be key in the rapid prevention and mitigation of future zoonotic events....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:bioRxiv
Main Authors: Martinez, David R., Schaefer, Alexandra, Gobeil, Sophie, Li, Dapeng, De la Cruz, Gabriela, Parks, Robert, Lu, Xiaozhi, Barr, Maggie, Manne, Kartik, Mansouri, Katayoun, Edwards, Robert J., Yount, Boyd, Anasti, Kara, Montgomery, Stephanie A., Shen, Shaunna, Zhou, Tongqing, Kwong, Peter D., Graham, Barney S., Mascola, John R., Montefiori, David. C., Alam, Munir, Sempowski, Gregory D., Wiehe, Kevin, Saunders, Kevin O., Acharya, Priyamvada, Haynes, Barton F., Baric, Ralph S.
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8095197/
https://ncbi.nlm.nih.gov/pubmed/33948590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.04.27.441655
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados